Enterococcus faecium with high-level resistance to gentamicin.

Detection of high-level aminoglycoside resistance in enterococci other than Enterococcus faecalis. J Clin Microbiol (1991) 1.56

Enterococcus faecium with high-level resistance to gentamicin. Lancet (1991) 1.46

Comparison of high-level gentamicin-resistant Enterococcus faecium isolates from different continents. Antimicrob Agents Chemother (1993) 1.28

Enterococcus faecium with high-level resistance to gentamicin. Lancet (1991) 0.81

Vancomycin-resistant enterococci. Lancet (1988) 11.27

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06

Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci U S A (1989) 5.65

BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax (2009) 5.23

Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet (1997) 5.22

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect (2012) 4.68

Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol (2000) 4.67

Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (2001) 4.15

Carbapenemases: a problem in waiting? Curr Opin Microbiol (2000) 3.98

High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect (1989) 3.95

Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev (1990) 3.82

IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother (2001) 3.80

Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect (2012) 3.58

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ (2000) 3.10

Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. BMJ (1996) 2.92

Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proc Natl Acad Sci U S A (1990) 2.82

Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill (2008) 2.78

Detection of the mec-A gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillinresistance. J Antimicrob Chemother (1996) 2.77

A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg (1985) 2.76

A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect (2011) 2.74

Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore. Lancet (1999) 2.68

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill (2013) 2.63

Characterization of the plasmid mediated beta-lactamase BIL-1. J Antimicrob Chemother (1992) 2.48

Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J Antimicrob Chemother (2011) 2.46

Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns. J Clin Microbiol (1996) 2.32

Molecular characterization of plasmids encoding CTX-M-15 beta-lactamases from Escherichia coli strains in the United Kingdom. J Antimicrob Chemother (2006) 2.12

Transmission of tuberculosis in British centre for patients infected with HIV. BMJ (1994) 2.11

Molecular epidemiology of Corynebacterium diphtheriae from northwestern Russia and surrounding countries studied by using ribotyping and pulsed-field gel electrophoresis. J Clin Microbiol (1995) 2.00

Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. J Clin Microbiol (1993) 1.95

Clostridium difficile colitis associated with chronic renal failure. Nephrol Dial Transplant (1998) 1.94

Antibiotic resistance of Shigella sonnei. Lancet (1970) 1.83

Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Dis Public Health (1998) 1.80

Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol (2004) 1.77

The need to retrieve the dropped stone during laparoscopic cholecystectomy. Am J Surg (1994) 1.76

A modified Elek test for detection of toxigenic corynebacteria in the diagnostic laboratory. J Clin Microbiol (1997) 1.74

DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains. J Clin Microbiol (1999) 1.71

Post-mortem radiology--a new sub-speciality? Clin Radiol (2008) 1.67

Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain. J Clin Microbiol (2002) 1.67

Antimicrobial resistance amongst enterococci isolated in the United Kingdom: a reference laboratory perspective. J Antimicrob Chemother (1993) 1.65

Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun (2001) 1.64

Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect (2009) 1.63

The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res (2000) 1.62

Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci. J Antimicrob Chemother (1998) 1.61

Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in Western Europe. Antimicrob Agents Chemother (2000) 1.61

Activity of mecillinam against ESBL producers in vitro. J Antimicrob Chemother (2005) 1.60

Carbapenemase-producing Pseudomonas aeruginosa in UK. Lancet (1998) 1.57

Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother (2010) 1.56

Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum (1984) 1.49

Laboratory guidelines for the diagnosis of infections caused by Corynebacterium diphtheriae and C. ulcerans. World Health Organization. Commun Dis Public Health (1999) 1.45

Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines. J Cell Physiol (2000) 1.45

Detection of glycopeptide resistance in clinical isolates of gram-positive bacteria. J Antimicrob Chemother (1991) 1.43

Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J Antimicrob Chemother (2010) 1.43

A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycin. Epidemiol Infect (1989) 1.42

Multiresistant acinetobacter in the UK: how big a threat? J Hosp Infect (2004) 1.39

Resurgence of tuberculosis. J Hosp Infect (1993) 1.38

Therapeutic drug monitoring of vancomycin in patients receiving haemodialysis: time for a change. J Clin Pathol (2006) 1.38

Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis? Lancet Infect Dis (2005) 1.37

Transferable cephalosporin resistance not inhibited by clavulanate in Escherichia coli. Lancet (1990) 1.37

Evaluation of serotype prediction by cpsA-cpsB gene polymorphism in Streptococcus pneumoniae. J Clin Microbiol (2000) 1.36

Healthcare-associated infections: think globally, act locally. Clin Microbiol Infect (2008) 1.35

The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. Br J Cancer (1999) 1.32

An investigation of nosocomial infection with Corynebacterium jeikeium in surgical patients using a ribosomal RNA gene probe. Eur J Clin Microbiol Infect Dis (1990) 1.31

Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in the prevention of outbreaks. J Hosp Infect (1992) 1.30

Comparison of high-level gentamicin-resistant Enterococcus faecium isolates from different continents. Antimicrob Agents Chemother (1993) 1.28

Glycopeptide-resistant enterococci isolated from uncooked meat. J Antimicrob Chemother (1996) 1.27

Tetracycline-resistant gonococci in UK. Lancet (1988) 1.26

Improved multiplex PCR strategy for rapid assignment of the four major Escherichia coli phylogenetic groups. J Clin Microbiol (2012) 1.26

Genetics of oxacillin resistance in clinical isolates of Streptococcus pneumoniae that are oxacillin resistant and penicillin susceptible. Antimicrob Agents Chemother (1994) 1.25

A twelve-year review of central nervous system bacterial abscesses; presentation and aetiology. Clin Microbiol Infect (2003) 1.24

Non-toxigenic Corynebacterium diphtheriae var gravis in England. Lancet (1993) 1.24

Carbapenem-resistant Klebsiella pnuemoniae in Singapore producing IMP-1 beta-lactamase and lacking an outer membrane protein. Antimicrob Agents Chemother (2001) 1.22

Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur J Clin Microbiol Infect Dis (2002) 1.22

Possible role of Helicobacter pylori serology in reducing endoscopy workload. Postgrad Med J (1994) 1.21

Diphtheria immunity in UK blood donors. Lancet (1995) 1.21

Outbreak of infection in two UK hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime. J Hosp Infect (1992) 1.20

Enterococci as emerging pathogens of humans. Soc Appl Bacteriol Symp Ser (1997) 1.20

Pneumococci causing invasive disease in Britain 1982-1990. J Med Microbiol (1998) 1.19

Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school. BMJ (2008) 1.18

Virulence factors in Escherichia coli with CTX-M-15 and other extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother (2007) 1.15

PCR-enzyme-linked immunosorbent assay and sequencing as an alternative to serology for M-antigen typing of Streptococcus pyogenes. J Clin Microbiol (1997) 1.15

Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother (2008) 1.15

Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg (1994) 1.14

Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents (2011) 1.14

The contribution of respiratory pathogens to the seasonality of NHS Direct calls. J Infect (2007) 1.13

Mathematical modeling of antimicrobial susceptibility data of Staphylococcus haemolyticus for 11 antimicrobial agents, including three experimental glycopeptides and an experimental lipoglycopeptide. Antimicrob Agents Chemother (1990) 1.13

Isolation of environmental mycobacteria from clinical specimens in south-east England: 1973-1993. Int J Tuberc Lung Dis (1997) 1.13

Nontoxigenic corynebacterium diphtheriae: an emerging pathogen in England and Wales? Emerg Infect Dis (2001) 1.12

Risk reducing mastectomy: outcomes in 10 European centres. J Med Genet (2008) 1.12

Frequency of esp in Enterococcus faecium isolates. Lancet (2001) 1.12

Peritonitis due to vancomycin-resistant Staphylococcus epidermidis. Lancet (1991) 1.11

Pulmonary tuberculosis in Kumasi, Ghana: presentation, drug resistance, molecular epidemiology and outcome of treatment. West Afr J Med (2001) 1.11

Current status of routine post-mortem CT in Melbourne, Australia. Forensic Sci Med Pathol (2007) 1.10